Bihua Chen

Bihua Chen is the founder of Cormorant Asset Management and portfolio manager for its public fund and private funds focusing primarily on innovative biotech and MedTech companies. Cormorant’s assets under management have grown from less than $150mm at the launch in May of 2013 to over $1.4 billion in 2019. Prior to founding Cormorant, Ms. Chen managed a separately managed account focused on the healthcare sector as a sub-adviser to a large, multi-strategy hedge fund based in New York. During Ms. Chen’s time managing the account (from 2005 through 2010) the account grew from $75 million in assets to $800 million in assets. Prior to that, Ms. Chen was a healthcare analyst/sector portfolio manager for American Express Asset Management, Boston. Ms. Chen has also served as a portfolio manager for the Asterion Life Science Fund (2001-2002), an equity analyst/portfolio manager for Bellevue Research (2000-2001), and an equity analyst for Putnam Investments (1998-2001). Ms. Chen obtained an MBA from the Wharton School of Business in 1998 and graduated with a Master of Science, Molecular Biology, from the Graduate School of Biomedical Science at Cornell Medical College in 1994. Ms. Chen also holds a Bachelor of Science degree in Genetics and Genetic Engineering from Fudan University, Shanghai, China, which she received in 1990.